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A B S T R A C T   
This study assesses COVID-19 vaccine intentions among a sample of older Syrian refugee beneficiaries of a 
humanitarian organization in Lebanon, and explores factors associated with vaccine refusal. The findings are part 
of an ongoing rotating 4-wave panel study. The sample was limited to participants from the first panel who 
completed a phone interview between January-February 2021. Out of 1,037 beneficiaries, almost a third (29%) 
reported no intention to vaccinate. Reasons for refusal were: newness of the vaccine (35%); preference to 
maintain precaution measures (21%); belief that the COVID-19 vaccine is not essential (21%); and other (23%). 
COVID-19 vaccine refusal was significantly associated with perceptions regarding vaccine safety (OR: 5.97; 95% 
CI: 4.03–8.84) and effectiveness (OR: 6.80; 95%CI:4.44–10.42) but did not differ by age, presence of chronic 
conditions, self-reported adherence to COVID-19 measures, and perceptions of susceptibility to and severity of 
COVID-19. Addressing vaccine hesitancy among Syrian refugees in Lebanon necessitates disseminating accurate, 
accessible, and culturally appropriate information about vaccine safety and effectiveness.   
1. Introduction 
Achieving COVID-19 herd immunity worldwide demands the 
implementation of equitable vaccination campaigns and overcoming 
multiple resource constraints such as accessibility to the vaccine, 
logistical capacities, and vaccine hesitancy(Chevallier et al., 2021; 
Schwarzinger et al., 2021). Existing studies on COVID-19 vaccine hesi-
tancy have focused on adults from the general population and health-
care workers(Sallam, 2021), with little evidence published on the 
perceptions of immigrants and refugees. As displaced populations are 
disproportionately affected by COVID-19 due to the syndemic effects of 
health and social vulnerabilities(Thomas and Osterholm, 2021), 
including them in national vaccination campaigns is paramount. 
The Arab region, which hosts one of the largest refugee populations 
worldwide, reports very low COVID-19 vaccine acceptance rates(Sal-
lam, 2021), with studies published shortly following vaccine rollout 
reporting that only 28.4% of adults in Jordan and 44% in Lebanon 
expressed willingness to get vaccinated(Sallam et al., 2021; Wouters 
et al., 2021). 
Lebanon launched its COVID-19 vaccination campaign on February 
14, 2021 pledging for an inclusive and equitable vaccination strategy. 
The national plan initially prioritised vaccinating healthcare workers, 
older people above age 65, and those aged 55–64 years with comor-
bidities (Ministry of Public Health, 2021). The two main vaccines pro-
vided by the Ministry of Public Health for free to the abovementioned 
priority social groups are Pfizer Biontech and AstraZeneca, although 
other vaccines were purchased by various labor sectors (i.e., banks and 
hospitality venues). Between February and August 2021, 2,365,852 
doses of the COVID-19 vaccine were administered; yet, only 1.9% were 
given to Syrians (Ministry of Public Health, 2021), highlighting stark 
inequities in vaccine access. Registration to receive the COVID-19 vac-
cine on the national platform among Syrians was also low with only 5% 
of total registered people being of Syrian nationality (Ministry of Public 
Health, 2021). 
There are 865,000 registered Syrian refugees in Lebanon, a country 
with a total population of 6 million (UNHCR) (UNHCR, 2021). To 
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achieve herd immunity and protect those who are most at risk of severe 
COVID-19 infection, it is critical that all Syrians residing in Lebanon 
receive the vaccine and especially older adults with co-morbidities. 
Understanding the factors associated with vaccine acceptance and 
refusal is key for public health planning to achieve this aim. Thus, this 
study assessed COVID-19 vaccine intentions among a sample of older 
Syrian refugees (≥50 years of age) in Lebanon, and explored factors 
related with vaccine refusal. 
2. Materials and methods 
The findings come from an ongoing rotating 4-wave panel study 
aiming to track the vulnerability of older Syrian refugees residing in 
Lebanon to COVID-19 and their adherence to public health measures. 
The sampling frame for the study was a beneficiary household list of the 
Norwegian Refugee Council, an international humanitarian organiza-
tion operating in Lebanon, with at least one adult aged 50 years or older. 
Data for the study were collected through phone interviews. The study 
sample size is 3,838; however, the findings presented here are limited to 
a sample of 1,037 from the first panel who were interviewed between 
January 21, 2021 and February 22, 2021, around the time Lebanon 
received its first batch of the COVID-19 vaccine in mid-February 2021. 
This study was granted approval by the Social and Behavioral Sci-
ences Institutional Research Board at the American University of Beirut. 
Participants voluntary agreed to participate in the study following oral 
consent and had the right to refuse or withdraw participation at any time 
without affecting their access to benefits. 
Intention to vaccinate against COVID-19 was assessed using the 
following question: “If a safe and effective vaccine for COVID-19 became 
available, free, would you take it?” (Yes, No, Don’t know, Refuse to 
answer). Using unadjusted logistic regression analyses, we examined the 
association between vaccine refusal and five constellations of factors: 1. 
Socio-demographics; 2. Presence of chronic illness; 3. General percep-
tions of vaccine safety and effectiveness; 4. Adherence to COVID-19 
measures; 5. Perceptions of susceptibility to and severity of COVID-19. 
3. Results 
The majority of the sample (66%) reported an intention to receive 
the COVID-19 vaccine if it is safe and free; almost one third (28.8%) 
reported no intention to vaccinate and 5.2% didn’t know or refused to 
answer. Among those who reported no intention to vaccinate, the rea-
sons provided were: newness of the vaccine and wanting to wait to know 
more (35%); preference to maintain public health precautions (21%); 
belief that the vaccine is not essential (21%); and other reasons (23%) 
including worry about the side effects of the vaccine, interactions with 
other medications, and lack of trust in the system. 
The findings in Table 1 demonstrate that COVID-19 vaccine accep-
tance was not associated with sex, age, or education; however, the odds 
of refusal were statistically significantly higher among refugees living 
outside informal tented settlements (ITSs) compared to those inside 
ITSs. Those in the 70 + age category and those reporting chronic con-
ditions did not significantly differ from younger participants or those 
without chronic conditions in their vaccine acceptance. This finding has 
important implications given that these are the two most at risk groups 
of COVID-19 severe illness and mortality(Zhou et al., 2020). Perceptions 
of vaccine safety and effectiveness were significantly associated with 
vaccine acceptance; for example, those who disagreed with the state-
ment that vaccines are safe were six times more likely to report refusal to 
vaccinate compared to those who agreed with the statement. Finally, 
self-reported adherence to COVID-19 public health measures and per-
ceptions of susceptibility to and severity of COVID-19 were not associ-
ated with vaccine acceptance. 
4. Discussion 
The majority of older Syrian refugees reported the intention to 
receive the COVID-19 vaccine; however, a third reported refusing to 
receive it citing such reasons as the newness of the vaccine, the belief 
that it is not essential, or preference to continue to follow COVID-19 
precautions. Surprisingly, older age, and presence of chronic condi-
tions were not associated with COVID-19 vaccine acceptance, nor were 
self-reported adherence to COVID-19 measures and perceptions of sus-
ceptibility to and severity of COVID-19. On the other hand, the factors 
associated with vaccine refusal included perceptions surrounding the 
safety and effectiveness of vaccines and residing outside ITSs. 
In the context of Lebanon, our findings show that Syrians tended to 
have a higher reported intention to receive the vaccine than the Leb-
anese population as revealed in recent studies. For example, findings 
from a cross-sectional survey of a small, non-representative sample of 
Lebanese adults and an online survey of 1,185 Lebanese participants 
reported COVID-19 intention at 21% and 46%, respectively (Al Halabi 
et al., 2021; Abou-Arraj et al., 2021). Vaccine intention was also low 
among populations in other Arab countries such as Kuwait (23.6%), 
Jordan (28.4%), and Saudi Arabia (31.8%)(Sallam et al., 2021). Older 
adults and refugees were underrepresented in these studies, which may 
explain the lower reported intentions in comparison to what we found 
among older Syrian refugees in Lebanon. 
COVID-19 vaccine refusal was higher among Syrians living outside 
ITSs compared to those living inside. This may be explained by the fact 
that most humanitarian programming focuses on refugees inside set-
tlements that have clear geographic boundaries as they are easier to 
locate. As such, Syrian refugees inside ITSs may have received more 
information about the benefits of vaccination compared to refugees who 
are difficult to reach outside ITSs. This highlights the need to focus ef-
forts on reaching the “hard-to-reach” refugees who are geographically 
dispersed in urban and rural settings. Moreover, unlike other studies 
that found age and education to predict vaccine refusal/acceptance 
(Sallam, 2021; Sallam et al., 2021; Abou-Arraj et al., 2021), these two 
important sociodemographic factors did not show an association in our 
study. This might be explained by the lack of variability in age and 
education level in this disadvantaged refugee population as only 12% of 
the study sample were 70 years of age or older and the majority reported 
low education. 
Similar to other studies (Schwarzinger et al., 2021; Sallam, 2021; 
Abou-Arraj et al., 2021; Fisher et al., 2020), ours showed that lack of 
trust, limited knowledge about the vaccine, and negative perceptions 
around vaccine effectiveness were associated with higher vaccine 
refusal. Refusal of new vaccines has been found to further exacerbate in 
settings of low trust such as that of Lebanon, a country witnessing deep 
political and economic crises. Vaccine refusal varies with time, context, 
and the nature of the vaccine itself, and the phenomenon was shown to 
be attributed to Complacency, Convenience and Confidence, also known 
as the “3Cs” model involving individual, contextual, and vaccine-related 
factors (WHO, 2014). It has been suggested that perceptions around 
risks versus complacency, affordability, and convenience (availability of 
and accessibility to vaccines) contribute to explaining vaccine intention 
and acceptance. On the other hand, mistrust in vaccines’ safety and 
effectiveness, as well as a more generalized mistrust of the pharma-
ceutical industry, government, and healthcare providers predict vaccine 
refusal (WHO, 2014). Hence, an understanding of all of these factors is a 
necessary component of the design of vaccination plans and health 
promotion and communication strategies. 
5. Strengths and limitations 
The data used in the present analysis come from the first of a three 
panel study and may have lacked statistical power to detect sex and age 
differences in vaccine refusal. Specifically, we did not have enough 
statistiscal power to carry out meaningful analysis on the vaccine 
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Table 1 




Acceptance of COVID-19 
vaccine  
(n = 684 (66.0%)) 
Refusal of COVID-19 
vaccine  
(n = 299 (28.8%)) 
Undecided  
(n = 54 
(5.2%)) 
Refusal of COVID-19 
vaccinea  
n (%) n (%) n (%) n (%) OR (95% CI) 
Socio- Demographics      
Age (years)      
50–59 629 
(60.7) 
420 (66.8) 184 (29.2) 25 (4.0) 1 
60–69 282 
(27.2) 
184 (65.2) 77 (27.3) 21 (7.5) 0.96 (0.70–1.31) 
70+ 126 
(12.2) 
80 (63.5) 38 (30.2) 8 (6.3) 1.08 (0.71–1.66) 
Sex      
Male 579 
(55.8) 
394 (68.1) 157 (27.1) 28 (4.8) 1 
Female 458 
(44.2) 
290 (63.3) 142 (31.0) 26 (5.7) 1.23 (0.94–1.61) 
Residence      
Inside informal tented settlements (ITS) 402 
(38.8) 
283 (70.4) 102(25.4) 17 (4.2) 1 
Outside ITS 635 
(61.2) 
401 (63.2) 197 (31.0) 37 (5.8) 1.36 (1.03–1.81) 
Education      
Never attended school 479 
(46.4) 
317 (66.2) 129 (26.9) 33 (6.9) 1 
Attended school 554 
(53.6) 
364 (65.7) 169 (30.5) 21 (3.8) 1.14 (0.87–1.50) 
Health      
Chronic conditions      
None 277 
(27.8) 
182 (65.7) 80 (28.9) 15 (5.4) 1 
At least one 718 
(72.2) 
472 (65.7) 207 (28.8) 39 (5.4) 1.00 (0.73–1.36) 
Hypertension      
No 601 
(60.6) 
394 (65.5) 173 (28.8) 34 (5.7) 1 
Yes 390 
(39.4) 
258 (66.2) 112 (28.7) 20 (5.1) 0.99 (0.74–1.31) 
Diabetes      
No 771 
(77.6) 
513 (66.5) 220 (28.5) 38 (4.9) 1 
Yes 222 
(22.4) 
140 (63.1) 66 (29.7) 16 (7.2) 1.10 (0.79–1.53) 
Vaccination Perceptions      
I think vaccines are safe      
Agree 670 
(64.6) 
504 (75.2) 144 (21.5) 22 (3.3) 1 
Neither agree nor disagree or Don’t know 211 
(20.4) 
129 (61.1) 68 (32.2) 14 (6.6) 1.84 (1.30–2.61) 
Disagree 156 
(15.0) 
51 (32.7) 87 (55.8) 18 (11.5) 5.97 (4.03–8.84) 
I think vaccines are effective      
Agree 680 
(65.6) 
510 (75.0) 148 (21.8) 22 (3.2) 1 
Neither agree nor disagree or Don’t know 226 
(21.8) 
145 (59.7) 74 (32.7) 17 (7.5) 1.89 (1.35–2.65) 
Disagree 131 
(12.6) 
39 (29.8) 77 (58.8) 15 (11.4) 6.80 (4.44–10.42) 
COVID-19 Adherence Measures      
Attended social events      
No 934 
(94.0) 
613 (65.6) 269 (28.8) 52 (5.6) 1 
Yes 60 (6.0) 40 (66.7) 18 (30.0) 2 (3.3) 1.02 (0.58–1.82) 
Mainly stayed at home except for essential purchasing      
No 197 
(19.8) 
127 (64.5) 60 (30.4) 10 (5.1) 1 
Yes 798 
(80.2) 
527 (66.0) 227 (28.5) 44 (5.5) 0.91 (0.65–1.29) 
Received visitors at home      
No 675 
(67.8) 
436 (64.6) 197 (29.2) 42 (6.2) 1 
Yes 320 
(32.2) 
218 (68.1) 90 (28.1) 12 (3.8) 0.91 (0.68–1.23) 
Worn a mask      
No 88 (68.8) 36 (28.1) 4 (3.1) 1 
(continued on next page) 
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heistant group, which is a unique group that can be swayed towards 
vaccine acceptance. In addition, data collection occurred prior to the 
commencement of the vaccination program in January and February 
2021 in Lebanon and therefore it is possible that vaccination intentions 
have changed since then. Despite these limitations, this study was 
relatively large compared to others completed in Lebanon and provides 
insight to tailoring the vaccination rollout amongst Syrian refugees. 
6. Conclusion 
These preliminary findings highlight important directions towards 
enhancing vaccine acceptance among Syrian refugees in Lebanon to 
reach herd immunity, reduce rates of severe infections, and ensure that 
Syrian refugees, who make up a significant proportion of the resident 
population in the country, are not left behind. Although vaccine 
acceptance among Syrian refugees in our sample was higher than that of 
the general adult population in Lebanon, refugees may face particular 
challenges in vaccine registration and access. In Lebanon, where Syrian 
refugees experience security, mobility, and healthcare access barriers, 
humanitarian organisations ought to consider delivery of immunization 
services to older refugees inside and outside ITSs. Practical approaches 
include disseminating accurate, accessible, and culturally appropriate 
information about vaccine safety and effectiveness. Importantly, these 
public health information campaigns must tackle the unprecedented 
surge of misinformation ‘infodemic’ about COVID-19 vaccines(Makhoul 
et al., 2021); consider the integration of “3Cs” model of vaccine hesi-
tancy; and work with community leaders, organisations and other key 
influencers to improve confidence, re-establish trust and address 
possible determinants influencing vaccine acceptability among Syrian 
refugees. 
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